Taking daily low-dose aspirin could almost halve the risk of colorectal cancer recurrence for some patients whose tumors have a particular genetic mutation, a new study finds.

New England Patriots head coach Mike Vrabel provided an unfortunate medical update on defensive coordinator Terrell Williams on Friday.

Dr. Kimmie Ng of Dana-Farber Cancer Institute discusses challenges unique to patients with young-onset colorectal cancer.

News Politics Tech Fact Check Personal Finance Automotive Sports Better Workplaces

If more and more young people are dying of colorectal cancer, why aren't we talking about it? Is it because we're too ashamed of our bodies?Rates of colorectal cancer are rising, especially for people under 50. But it's hard to raise awareness for a cancer that a lot of us find hard to talk about. In a recent essay for The Cut, writer Laurie Abraham described her experience of colon cancer, which included a lot of embarrassment. Talking about your bowel movements is...not fun. Can you relate?Today, Brittany is joined by Laurie and Dr. Kimmie Ng, Co-Director of the Colon and Rectal Cancer Center at the Dana-Farber Cancer Institute, to get into the cultural shame around how we talk about colon cancer - and how that extends to a lack of funding and research.Follow Brittany Luse on Instagram: @bmluseFor handpicked podcast recommendations every week, subscribe to NPR's Pod Club newsletter at npr.org/podclub.

Boston 25 Weather The Local Life(Opens in new window) Share your pics(Opens in new window)

Lung cancer screening guidelines do not exist for individuals who never smoked, but data presented at International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer indicate they may be necessary.In a study of 1,000 Asian women who never smoked, low-dose CT detected lung cancer at a similar rate as trials that included patients with elevated risk.

Dr Wen discussed the significance of the FDA approval of dordaviprone for patients at least 1 year of age with H3K27M-mutated diffuse midline glioma.

Researchers explore innovative macrocyclic peptides to target small cell lung cancer, revealing promising therapeutic strategies for this aggressive disease.

When his pancreatic cancer recurred, Bob Fortin was given 10 months to live-but a clinical trial of a new targeted therapy has stabilized his cancer.

Boston 25 Weather The Local Life(Opens in new window) Share your pics!(Opens in new window)

Published: May 19, 2025Written by: Lukas Harnisch-WeidauerMedically Reviewed By: Mark Pomerantz, MDAmong cancer diagnoses, prostate cancer is relatively common, especially for those who are older than 65. Fortunately, it is often manageable with minimal interventions necessary for a substantial portion of patients. However, many prostate cancer cases can be categorized as "aggressive," meaning it will require more ... Read more

A lump behind the ear could be many things, including just an infected bug bite. What else could it be, and when should you see a doctor?

Aggressive prostate cancer treatment is evolving. Find out how new therapies are changing outcomes and patient care.

Published: May 14, 2025Written by: Beth DoughertyDana-Farber researchers have discovered ancient bacterial defenses and anti-defenses that may persist in some form in humans today and could provide insights into new approaches to cancer research and treatment. The tripwire is a go-to booby trap in movies. An aggressor trips over an unseen wire, setting off a ... Read more

Chaplains, like many caregivers focused on the mind, heart or soul, are realizing that the inner lives of many of their patients are turned inside out and made visible through their tattoos. Some chaplains say tattoos are an invaluable to get to patients and understand their spiritual needs.